TScan Therapeutics (NASDAQ:TCRX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does TScan Therapeutics (TCRX) operate in?

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open	$2.23
Close	$2.17
Volume / Avg.	513.67K / 453.41K
Day Range	$2.15 - $2.33
52 Wk Range	1.99 - 9.69
Market Cap	$124.24M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	4.35%
Days to Cover	8.89

Recent News

Why Is TScan Therapeutics Stock Gaining Today?

TScan Therapeutics' stock rises after announcing a $30 million financing deal with Lynx1, extending its cash runway into 2027.

Nabaparna Bhattacharya

Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

Avi Kapoor

Around $10M Bet On This Real Estate Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed higher by around 10 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.23
Close	$2.17
Volume / Avg.	513.67K / 453.41K
Day Range	$2.15 - $2.33
52 Wk Range	1.99 - 9.69
Market Cap	$124.24M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	4.35%
Days to Cover	8.89

About Tscan Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy TScan Therapeutics (TCRX) stock?

You can purchase shares of TScan Therapeutics (NASDAQ:TCRX) through any online brokerage.

View our list of the best stock brokerages

Who are TScan Therapeutics (TCRX) competitors?

Other companies in TScan Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Cabaletta Bio (NASDAQ:CABA), Anixa Biosciences (NASDAQ:ANIX), Atossa Therapeutics (NASDAQ:ATOS) and Elicio Therapeutics (NASDAQ:ELTX).

What is the forecast, or price target, for TScan Therapeutics (TCRX) stock?

TScan Therapeutics has a consensus price target of $11.40.

What is the current price for TScan Therapeutics (TCRX)?

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $2.1987 last updated February 21, 2025 at 7:57 PM EST.

Does TScan Therapeutics (TCRX) pay a dividend?

A quarterly cash dividend of 0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

TScan Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is TScan Therapeutics (TCRX) going to split?

There is no upcoming split for TScan Therapeutics.

What sector and industry does TScan Therapeutics (TCRX) operate in?

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

TScan Therapeutics

TScan Therapeutics (TCRX) Forecast